.svg){kind=small}
Jul-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Emerald Bay Extracts has shown a consistent presence in the California market, particularly in the Capsules category where they have maintained a steady ranking of 5th place from May through July 2025. Despite this consistency, their sales in this category have seen a downward trend, with sales figures decreasing from April's peak. This could suggest a need for strategic adjustments to maintain their position or potentially improve it. In the Concentrates category, Emerald Bay Extracts experienced some fluctuations in their rankings, moving from 21st in April, briefly dropping to 25th in June, and then climbing back to 21st in July. This indicates a competitive landscape where maintaining a stable rank requires continuous effort and adaptation to market changes.
In the Tincture & Sublingual category, Emerald Bay Extracts did not rank in the top 30 in April, but they made a significant entry into the rankings by May, securing 17th place and subsequently climbing to 14th by July. This upward trajectory highlights a positive momentum in this category, potentially driven by effective product offerings or marketing strategies that resonated well with consumers. While this growth is promising, the absence from the top 30 in April serves as a reminder of the volatility and challenges in gaining a foothold in this segment. Overall, while Emerald Bay Extracts has shown strength in certain categories, the varying performances across these categories suggest areas where the brand could focus on to bolster their market presence further.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, Emerald Bay Extracts has experienced a slight decline in its ranking from April to July 2025, moving from 4th to 5th position. This shift is primarily influenced by the consistent performance of Kikoko, which improved its rank from 5th to 4th, maintaining steady sales figures around the mid $400,000s. Despite this, Emerald Bay Extracts remains competitive, with sales figures that, while declining, still position it closely behind Kikoko. Meanwhile, ABX / AbsoluteXtracts holds a strong 3rd place with significantly higher sales, indicating a robust market presence. Other competitors like Buddies and Papa & Barkley maintain stable ranks, but their sales figures suggest less immediate threat to Emerald Bay Extracts' position. This competitive dynamic underscores the importance for Emerald Bay Extracts to strategize on regaining its rank and stabilizing sales amidst a competitive and evolving market.
Notable Products
In July 2025, the top-performing product for Emerald Bay Extracts was the Blue Dream RSO Syringe (1g) from the Concentrates category, which climbed to the number one spot with sales of 1328.0. The Glitter Bomb RSO Syringe (1g), also in the Concentrates category, debuted impressively at the second position. The CBG White RSO Tablets 40-Pack (1000mg CBG) maintained a consistent third-place ranking, showcasing stable demand across the months. Meanwhile, the Blue Dream RSO Tablets 40-Pack (1000mg) fell to fourth place after leading in June. Lastly, the Ice Cream Cake RSO Syringe (1g) saw a significant drop from its previous top rankings, landing at fifth place in July.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
